ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WAI LEUNG M.D.

Cardiovascular Disease

35,052

$3.13M

1302
1220 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 31%

$89
Average prescription price

Avg: $75

JIONG-MING HU M.D., PH.D

Cardiovascular Disease

21,218

$1.32M

804
730 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 31%

$62
Average prescription price

Avg: $75

VINA PATEL M.D.

Cardiovascular Disease

20,958

$1.37M

489
377 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 31%

$65
Average prescription price

Avg: $75

MIRZA ASHRAF M.D.

Cardiovascular Disease

20,957

$1.1M

719
581 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 31%

$53
Average prescription price

Avg: $75

STEVE TAM MD

Cardiovascular Disease

19,983

$2.61M

787
751 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 31%

$130
Average prescription price

Avg: $75

ALEXANDER SHAKNOVICH M.D.

Cardiovascular Disease

19,646

$1.35M

1020
996 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 31%

$69
Average prescription price

Avg: $75

ELISCER GUZMAN MD

Cardiovascular Disease

18,414

$1.39M

1526
1207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 31%

$75
Average prescription price

Avg: $75

ALEXANDER MORDEN MD

Cardiovascular Disease

18,116

$1.19M

588
533 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 31%

$66
Average prescription price

Avg: $75

BYAGARI NARAYANA M.D.

Cardiovascular Disease

17,601

$818K

444
335 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$46
Average prescription price

Avg: $75

CHARLES HWU MD

Cardiovascular Disease

17,516

$547K

509
466 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 31%

$31
Average prescription price

Avg: $75

JAI RHEE

Cardiovascular Disease

14,637

$1.55M

386
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 31%

$106
Average prescription price

Avg: $75

THOMAS BIZZARO MD

Cardiovascular Disease

14,594

$965K

528
471 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 31%

$66
Average prescription price

Avg: $75

ALEX RACCO DO

Cardiovascular Disease

14,351

$1.25M

876
763 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$87
Average prescription price

Avg: $75

HOWARD FRIEDMAN MD

Cardiovascular Disease

14,065

$806K

431
401 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 31%

$57
Average prescription price

Avg: $75

LUIS GLODOWSKI MD

Cardiovascular Disease

13,959

$1.69M

631
513 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 31%

$121
Average prescription price

Avg: $75

FRANK TUNG M.D.

Cardiovascular Disease

13,837

$1.45M

1493
1407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 31%

$105
Average prescription price

Avg: $75

ELENA VEZZA M.D.

Cardiovascular Disease

13,777

$781K

443
404 are 65+

9%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 31%

$57
Average prescription price

Avg: $75

JOHN SAYAD MD

Cardiovascular Disease

13,734

$795K

545
491 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 31%

$58
Average prescription price

Avg: $75

LEONID CHERNOV M.D.

Cardiovascular Disease

13,179

$843K

624
546 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 31%

$64
Average prescription price

Avg: $75

WARREN CHIN MD

Cardiovascular Disease

13,175

$925K

433
392 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 31%

$70
Average prescription price

Avg: $75

CHAIM LEVINE MD

Cardiovascular Disease

13,165

$987K

563
512 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 31%

$75
Average prescription price

Avg: $75

NORMAN RIEGEL M.D., F.A.C.C.

Cardiovascular Disease

13,147

$992K

962
854 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$75
Average prescription price

Avg: $75

FARAH ATALLAH-LAJAM MD

Cardiovascular Disease

12,686

$790K

1035
895 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 31%

$62
Average prescription price

Avg: $75

ALEKSEY KAMENETSKIY MD

Cardiovascular Disease

12,432

$911K

833
786 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 31%

$73
Average prescription price

Avg: $75

MIKHAIL KAPCHITS M.D.

Cardiovascular Disease

11,953

$1.09M

673
623 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 31%

$91
Average prescription price

Avg: $75

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank